Effect of enriched environment during adolescence on spatial learning and memory, and voluntary consumption of morphine in maternally separated rats in adulthood. Issue 4 (28th November 2018)

• Record Type: Journal Article
• Authors: Mohammadian, Javad; Najafi, Mahmoud; Miladi‐Gorji, Hossein
• Is Part Of: Developmental psychobiology. Volume 61:Issue 4(2019)
• Page Start: 615
• Page End: 625
• Publication Date: 2018-11-28
• Subjects: enriched environment -- maternal separation -- spatial learning and memory -- voluntary consumption of morphine; Psychobiology -- Periodicals; 155
• DOI: 10.1002/dev.21808
• Languages: English
• ISSNs: 0012-1630

Abstract

Abstract: This study was designed to examine the effect of environmental enrichment (EE) during adolescence on spatial learning and memory and voluntary morphine consumption in maternally separated (MS) male and female rats in adulthood. Male Wistar rats were allowed to mate with female virgin Wistar rats. Pups were separated from the dams daily for 180 min during postnatal days 2–14. All pups were weaned on day 21. The pups of both sexes were reared in a standard (SE) or enriched (EE) environment during postnatal days 21–50. Then, adulthood rats were tested for spatial learning and memory (Morris Water Maze), and voluntary consumption of morphine using a two‐bottle choice paradigm (TBC). We found that the MS/SE rats showed longer escape latencies to find the platform on the third (the male) and fourth (the female) days of training than No MS/SE rats. Also, exposure to EE shortened the latency to escape in the male and female MS rats as training progressed than MS/SE rats. Moreover, the No MS/EE and MS/EE male rats spent significantly more time in the target zone compared with the SE control groups in the probe test. We also found that voluntary morphine consumption was higher in the male and female MS/SE than No MS/SE rats, while it was lower in the male and female MS/EE rats. The present results have shown that EE treatment may have potential therapeutic application for the prevention of the development of drug addiction and recovery from cognitive deficits following neonatal MS during adulthood.